T-Cell Engager

SAN DIEGO, California, United States — October 27, 2026 Calidi Biotherapeutics, Inc., a biotechnology company developing targeted genetic medicines,...

CAMBRIDGE, Mass. — September 9, 2026 Crossbow Therapeutics, Inc. announced dosing of the first participant in the Phase 1...

North Chicago, Illinois, USA, September 3, 2026 AbbVie has announced positive topline results from the Phase 3 CERVINO trial,...

WATERTOWN, Mass., September 2, 2026 Treeline Biosciences, Inc. announced a clinical trial collaboration and supply agreement with Roche to...

Miramar, Fla. – August 25, 2026 HCW Biologics announced new findings supporting its TGF-β trap and IL-15 fusion moiety...

Tokyo, Japan, August 25, 2026 Astellas Pharma Inc. announced that the first patient has been dosed in a Phase...

MIRAMAR, Fla., August 14, 2026 HCW Biologics Inc. (NASDAQ: HCWB) reported second-quarter 2026 business and clinical development updates, highlighting...

NANJING, China, August 4, 2026 Leads Biolabs announced that its partner Oblenio Bio, a company jointly established with Aditum...

SAN DIEGO, July 27, 2026 Calidi Biotherapeutics presented new preclinical data from its CLD-401 program and its in situ...

NANJING, China, July 13, 2026 Leads Biolabs has strengthened its position in global cancer immunotherapy after announcing that six...